Understanding basic processes of human neural stem cell (hNSC) biology and differentiation is crucial for the development of cell replacement therapies. Bcl-X L has been reported to enhance dopaminergic neuron generation from hNSCs and mouse embryonic stem cells. In this work, we wanted to study, at the cellular level, the effects that Bcl-X L may exert on cell death during differentiation of hNSCs, and also on cell fate decisions and differentiation. To this end, we have used both v-myc immortalized (hNS1 cell line) and non-immortalized neurosphere cultures of hNSCs. In culture, using different experimental settings, we have consistently found that Bcl-X L enhances neuron generation while precluding glia generation. These effects do not arise from a glia-to-neuron shift (changes in fate decisions taken by precursors) or by only cell death counteraction, but, rather, data point to Bcl-X L increasing proliferation of neuronal progenitors, and inhibiting the differentiation of glial precursors. In vivo, after transplantation into the aged rat striatum, Bcl-X L overexpressing hNS1 cells generated more neurons and less glia than the control ones, confirming the results obtained in vitro. These results indicate an action of Bcl-X L modulating hNSCs differentiation, and may be thus important for the future development of cell therapy strategies for the diseased mammalian brain. The efficient generation of human neurons and glia from stem cells is the object of intense investigation, in the context of basic and preclinical cell replacement research.
1
Understanding basic processes of human neural stem cell (hNSC) biology and differentiation is crucial for the development of cell replacement therapies. Bcl-X L has been reported to enhance dopaminergic neuron generation from hNSCs and mouse embryonic stem cells. In this work, we wanted to study, at the cellular level, the effects that Bcl-X L may exert on cell death during differentiation of hNSCs, and also on cell fate decisions and differentiation. To this end, we have used both v-myc immortalized (hNS1 cell line) and non-immortalized neurosphere cultures of hNSCs. In culture, using different experimental settings, we have consistently found that Bcl-X L enhances neuron generation while precluding glia generation. These effects do not arise from a glia-to-neuron shift (changes in fate decisions taken by precursors) or by only cell death counteraction, but, rather, data point to Bcl-X L increasing proliferation of neuronal progenitors, and inhibiting the differentiation of glial precursors. In vivo, after transplantation into the aged rat striatum, Bcl-X L overexpressing hNS1 cells generated more neurons and less glia than the control ones, confirming the results obtained in vitro. These results indicate an action of Bcl-X L modulating hNSCs differentiation, and may be thus important for the future development of cell therapy strategies for the diseased mammalian brain. The efficient generation of human neurons and glia from stem cells is the object of intense investigation, in the context of basic and preclinical cell replacement research.
1,2 Different means of genetic and epigenetic manipulations of stem cell cultures are being tested, aiming at enhancing their ability to generate the desired cell types. [3] [4] [5] [6] In previous studies, we and others have demonstrated that Bcl-X L overexpression has a major impact on the generation of dopaminergic neurons from human neural stem cells (hNSCs) and mouse embryonic stem cells (mES). 7, 8 Also, recent data from conditional Bcl-X L mutant mice add support to these observations. 9, 10 In the present study, we are extending these observations and analyzing in detail the effects of Bcl-X L on hNSCs differentiation, focusing on precursor cell fate choices, cell death, and precursor proliferation.
Bcl-X L is the most potent antiapoptotic protein among Bcl-2 family members, both in vitro and in vivo. [11] [12] [13] [14] More specifically, Bcl-X L is essential for neuronal survival during brain development and in the adult central nervous system (CNS) (knockout mice and gene-expression studies 15, 16 ). In addition to its antiapoptotic role, recent studies have described new roles of Bcl-X L in cell physiology -effects on Ca 2 þ homeostasis and gene expression 17 and synaptic transmission regulation 18 -under not necessarily apoptotic conditions. Several other studies have also described the role of Bcl-X L in the control of cell cycle, 19, 20 a process well known to be tightly linked to progression of precursor cells toward neuronal and glia differentiation. 21, 22 In this work, we aimed to elucidate the role of Bcl-X L in the generation of neurons and glia from both v-myc immortalized and non-immortalized hNSCs.
In vivo, numerous studies have shown that hNSCs can integrate, migrate, and differentiate when transplanted into the developing or young adult rodent and primate brain. 1, 2, [23] [24] [25] Since neurodegenerative diseases are in many cases lateonset diseases, we found therefore of interest to study the in vivo properties of control or Bcl-X L overexpressing hNS1 cells after transplantation into the aged rat brain. Consistent with the in vitro data, we have also observed an increased neuron production and a diminished glia yield from Bcl-X L -overexpressing hNS1 cell transplants.
Results
Effects of Bcl-X L on hNSCs differentiation. When studying the yield of b-III-tubulin þ cells and GFAP þ cells by control or stable Bcl-X L hNS1 cells after 12 days of differentiation, we observed some interesting effects: (i) an increase in the percentage of neurons (8. Figure 1f , Bcl-X L protein levels were increased in Bcl-X L cells as compared to the controls, both under proliferation and differentiation conditions.
The data just described were obtained from a stable clone of hNSCs overexpressing Bcl-X L for prolonged periods of time. To study Bcl-X L effects in a shorter time scale, we infected control hNS1 cells with retroviral vectors coding for Bcl-X L and green fluorescent protein (GFP), or only GFP (empty vector used as a control), on day 1 of differentiation, and the cells were let to differentiate until day 12. The efficiency of infection of both viral vector preparations was equivalent, as determined on day 3 post-infection (approximately 12-13% of GFP þ cells; Supplementary Figure S1 ). Phenotypic analysis of GFP þ cells after differentiation revealed that 70.371.4% of them in the Bcl-X L group were b-III-tubulin þ , while only 20.571.8% were b-III-tubulin þ in the control group (Po0.01; Student's t-test; n ¼ 4) (Figure 2a and b). On the contrary, the analysis of glial cell generation showed a significant reduction of GFP þ -GFAP þ cells in Bcl-X L transduced cells (14.471.3%) as compared with the empty vector group (34.470.9%) (Po0.05; Student's t-test; n ¼ 4) (Figure 2c and d) .
To rule out the possibility that the observed Bcl-X L effects could be related to an interaction of Bcl-X L with v-myc in the cellular context, we studied the effects of Bcl-X L on the differentiation of non-immortalized forebrain hNSCs. Cells were infected with the same vectors as described above, and their differentiation was studied. Efficiency of infection was in the range of 9-12%, similar to that seen in immortalized cells. As shown in Figure 2e -g, Bcl-X L overexpression resulted in a higher yield of neurons, and a parallel decrease in the number of GFAP þ cells generated. Therefore, the Bcl-X L effects described so far are not related to a prolonged exposure of the cells to high Bcl-X L levels, neither to v-myc nor the nature of the hNSCs (either cell lines or non-immortalized cultures).
Differentiation 'time course' of control or stable Bcl-X L overexpressing hNS1 cells. To obtain further insights into Bcl-X L effects, we studied the time course of differentiation of both control and Bcl-X L hNS1 cells. Neurons (b-III-tubulin þ cells) were generated at the same pace by both cell types. . Data represent means7S.E.M (n ¼ 5). Asterisks indicate a statistical difference between control and Bcl-X L cells on the indicated days (*Po0.05; **Po0.01; two-way ANOVA followed by post hoc Student's t-test). (b and e) These panels illustrate the comparative rate of neuron and glia generation for each cell type, after normalization of the data shown in (a and d) (a 100% value was assigned to the maximum absolute value in (a and d)). Note that the temporal profile for neuron generation is absolutely parallel for control and Bcl-X L cells. Also, that there can be a slight delay in the appearance of GFAP þ cells on days 3-7. (c and f): The differentiation time-course experiment shown in (a and d), was re-done to cover longer time points (days 12-21), to elucidate if there could be a delay in differentiation of glia. To avoid cell overconfluence related problems in this new experiment running over 3 weeks, cells were plated at a lower cell density (20 000 cells/cm 2 ). Analysis of the results (two-way ANOVA) failed to detect any time differences on day 12 and after in each group, neither for the case of glia nor for neurons, (P>0.05 in both cases). The asterisks in (c and f) indicate a statistical significant difference between control and Bcl-X L cells (two-way ANOVA, followed by post hoc Student's t-test; *Po0.05, **Po0.01). Last, cell density does not play any role in Bcl-X L effects reported in these experiments (comparison of data on day 12 in panels (a and d) to those of (c and f), Student's t-test; P>0.1). The percentages of Map-2 þ and synapsin-I þ cells are represented in (g and h), respectively. Both graphs show a similar profile to that observed in the b-III-tubulin þ cells graph, thus not detecting an early appearance of a mature phenotype in overexpressing Bcl-X L cells compared to hNS1 cells. In the Map-2 data, there are statistical differences between the two cell types (two-way ANOVA, cellular effect F (6, 37) Figure 4d ). Data obtained with all four techniques illustrate that cell death is not a major event taking place in our system during the differentiation 'time course'. The proportion of alive and dead-dying cells did not substantially change with time.
To obtain further insights, we assessed the undergoing apoptosis for every phenotype along the differentiation period. We quantified the number of cells co-labeled for cleaved caspase-3 and b-III-tubulin, GFAP and nestin, respectively (Figure 4e-g). As shown in Figure 4e and f, Bcl-X L protects the neurons and neural cells against cell death as compared to controls, but at very low rate (less than 2%). Moreover, we have not found any double caspase-3
Bcl-X L effects on cell proliferation during the differentiation period. To investigate Bcl-X L effects on cell proliferation, we first performed a pulse and chase experiment ( Figure 5a ). Using this experimental design, we detected a trend for an increase in the number of cells incorporating bromodeoxyuridine (BrdU) in Bcl-X L cultures as compared with control hNS1 cells on days 3-5 of differentiation ( Figure 5b and e). Consistent with this, the total number of cells in the Bcl-X L cultures increased from day 5 onwards in comparison to control cultures ( Figure 5c ).
To have a second confirmation of the presence of proliferating cells in the cultures, we stained parallel samples for Ki-67 (a marker expressed during most of the cell cycle 26 ) and, as expected, we found more cells still in cycle in Bcl-X L cultures, from day 5 onwards (Figure 5d and e).
Bcl-X L modulates the production of neurons and glia from their precursors. Since cell death or differences on the time set of neurons and glia production were not the decisive cause of different yielding observed; and because existence of a trend on an increased proliferation in Bcl-X L cultures detailed above, we investigated what precursors of both cell types render on after the differentiation. With this aim, we pulsed the cells on different days and allowed them to differentiate until day 12 ( Figure 6a ). As Figure 6b and c show, there are higher number of cells that, when pulsed in the first days of differentiation, produce more neurons, detected as double in Bcl-X L overexpressing cells. We concluded that Bcl-X L is increasing the number of precursor proliferation that render on b-III-tubulin cells on day 12 or that these precursors differentiate more in Bcl-X L cultures, it means an induction of the neuron phenotype. In the case of GFAP cells, it is a matter of decreased precursor proliferation or a hampered differentiation.
Bcl-X L promotes the proliferation of neural (Nestin þ ) and neuronal precursor (b-III-tubulin þ ) cells at early times during differentiation of hNS1 cells but not of vimentin þ cells. In order to discern between the two possibilities raised on the above experiment, we analyzed the immediate phenotype of the proliferating cells during the differentiation period and studied Bcl-X L effects on them. We pulsed differentiating cell cultures for 24 h with BrdU (Figure 7a) , and the cells were subsequently processed for immunocytochemistry (ICC) (Figure 7b ).
Quantification of BrdU-or Nestin þ cells revealed a similar temporal profile for both markers over the studied time course (Figure 7c and d 27, 28 and that they were exposed to BrdU for 24 h only. Bcl-X L did not influence these figures substantially, but at days 3-4 of differentiation, a two-fold increase in the number of Nestin þ cells also incorporating BrdU was detected. Overall, Ki-67, Nestin, and BrdU data ( Figures 5 and 7b-e) suggest that Bcl-X L is promoting cell proliferation. Figure S2) .
Bcl-X L effects on hNS1 cell grafts into the aged rat striatum. Four weeks after intrastriatal cell implantation, three out of five rats receiving control cells, or four out of five animals implanted with Bcl-X L hNS1 cells had surviving grafts, as determined by the presence of human nuclei (hNuc) stained cells (Figure 8a ). hNuc þ cells were mainly located at the striatal implantation site and no signs of tumor formation were observed in any transplanted animals, according to previous studies. 8, 29, 30 Morphometric assessment of graft properties indicated that graft volume was larger for Bcl-X L cell grafts as compared to control cell grafts. (i) Antero-posterior extension of the grafts was 0.5370.13 mm in control grafts and 1.0970.11 mm in Bcl-X L transplants (Po0.05; Student's t-test). (ii) Total graft In agreement with previous results obtained in grafting studies in neonatal or young adult rats, 8, 29, 30 control hNS1 cells generated very few doublecortin (Dcx þ ) or human neuron-specific enolase (hNSE þ ) neurons when grafted into the striatum of aged rats, as expected from a non-neurogenic area, and aged tissue environment, receiving a NSCs graft. In contrast, Bcl-X L cell transplants were richer in Dcx þ and hNSE þ cells, as obvious from graft examination. Quantification of cell numbers was precluded by the high cell density of the grafted cells. Grafts of control hNS1 cells showed a dense (intense) GFAP immunoreactivity, sending an extensive network of processes to the host brain. GFAP immunoreactivity was also present in Bcl-X L grafts, but this was less intense and more confined to the transplant site.
Phenotypical identities of the grafted cells were analyzed by double labeling for hNuc þ and Nestin þ (undifferentiated precursors), Dcx þ (neuroblasts) or GFAP þ (glia), under confocal z axis serial images (Figure 8b) 
Discussion
Understanding how human stem cells can generate differentiated neural cell types is crucial for basic developmental studies and for the development of future cell therapies for nervous system diseases. 1,2 Our data indicate that transient Bcl-X L overexpression instructively direct the fate of both immortalized and naive hNSCs towards neurons while decreasing glia generation. These effects were even more prominent in stable Bcl-X L -overexpressing immortalized hNSCs, and they could be related to the following.
Survival. The antiapoptotic role of Bcl-X L has been well established in previous studies dealing with the differentiation of neural progenitors, and neural cells, in general. 9, 13, 14 Bcl-X L is required for neuronal survival during brain development and in the postnatal period. 16 Indeed, extensive apoptotic cell death was observed in the developing brain of Bcl-X Ldeficient mice embryos. 15 Bcl-X L has also been recently reported to play a crucial role in neuronal development/ survival in conditional null mice specific for catecholaminergic cells. 9 Our data indicated that total cell death is not playing a major role in our differentiation system neither in absolute terms, nor with time. However, and according to other studies, a decrease in apoptotic (caspase-3 þ ) cell death of Nestin þ and b-III-tubulin þ cells was observed in stable Bcl-X L overexpressing cells as compared to control hNS1 cells along the differentiation period. This antiapoptotic effect, even not irrelevant, seems to be too small to explain per se the high increase of in vitro generated neurons and the dramatic reduction in the yield of glial cells in Bcl-X L cultures, but we do not discard a minor protective effect in neural and neuronal cells.
Differentiation. When the b-III-tubulin and GFAP generation time courses are studied in detail, we conclude that Bcl-X L effects were due to the magnitude, not the rate, of neurons and glia generation. This observation was reinforced by the study of more mature neuronal markers (Map-2 and synapsin-I), which showed similar profiles of expression over time. Turning to glia, we also performed a time course to study vimentin cells, which decreased at the same pace for both cell types (control or Bcl-X L ). Similar results, in terms of neuron/glia generation were observed when cells were run until day 21 of differentiation, therefore discarding a possible 'delay of differentiation'.
Progenitor proliferation during hNS1 cell differentiation. BrdU incorporation data showed a trend for an increase in the number of BrdU þ cells in Bcl-X L cells as compared to control cultures on day 3 of differentiation. The percentages of Ki-67 þ cells, and total cell numbers were also significantly increased in Bcl-X L cultures after day 5 of differentiation. These results strongly indicate that Bcl-X L is modulating -cell proliferation in our system, in agreement with other reports. 19, 20 The analysis of the proliferation of neural precursor cells
, and neuronal progenitors (b-III-tubulin þ -BrdU þ ) showed: Firstly, the quantification of BrdU þ or Nestin þ cells confirmed the expected parallel temporal profile for both markers and Bcl-X L increased the numbers of stained cells during the whole of the differentiation period. These findings are consistent with results from studies using mES cells, 7 and bax-bak-deficient mice which displayed an increased pool of progenitor cells in the subventricular zone. 31 Second, quantification of double BrdU þ -Nestin þ cells indicated that most of the proliferating cells (BrdU þ ) were Nestin þ , while approximately one half of the Nestin þ cells incorporated BrdU. Moreover, Bcl-X L overexpression increased twofold the number BrdU þ -Nestin þ cells pulsed during days 3-4. These data suggest that Bcl-X L is promoting the proliferation of undifferentiated (Nestin þ ) cells (see Figure 9) . Third, BrdU incorporation into GFAP þ precursor cells was negligible, and Bcl-X L had no effect on this parameter. We performed the same BrdU marking strategy with vimentin cells and observed that they incorporated BrdU at the same rate even when Bcl-X L was overexpressed, allowing us to state that Bcl-X L does not affect the proliferation of immature glia. Finally, the number of neuronal precursor cells incorporating BrdU (b-III-tubulin þ -BrdU þ cells) was increased in Bcl-X L cultures. Overall, we concluded that Bcl-X L promotes the proliferation of neural precursors and neuronal progenitors, that the last phenomenon may be responsible for the increased number of post-mitotic neurons, and that the diminished production of glia is due to a block in differentiation of their precursors.
Regarding the mechanism explaining the increase in neuron generation observed here after Bcl-X L overexpression, it is important to highlight that cell proliferation has been shown to be a prerequisite for increased neuron generation in other studies. 22 Present results could be reminiscent to those observed after valproate (an inhibitor of histone deacetylase) treatment of human fetal forebrain stem cells. 5 Similarly, Wnts have been recently found to enhance neurogenesis from hippocampus-derived precursors, through the stimulation of neuroblast proliferation. 6 Also, pro-neural transcription factors of the helix-loop-helix family, such as neurogenin and Mash1 32, 33 have been reported to enhance neuron generation through an increased proliferation of their progenitors. In fact, Mash1 deletion mutant mice show decreased cell proliferation, and reduced brain size and neuronal generation/ differentiation in the ventral forebrain. 34 Moreover, the same transcription factors have been implicated in the inhibition of generation of glial cells. Future molecular and genetic studies will be needed to elucidate the molecular mechanisms responsible for the Bcl-X L effects described here.
In vivo, after transplantation into the aged rat striatum (to mimic the situation of a late-onset disease, with a preclinical orientation), grafts of Bcl-X L overexpressing hNS1 cells survived better, and contained more neuronal cells and less glial cells than control hNS1 cell grafts. Similarly, mouse ES cells overexpressing Bcl-X L showed a better reinnervation of the striatum of 6-OH-DA rats. 7 In the present work, it is important to note that Bcl-X L did enhance hNSCs survival and neuronal differentiation, when implanted in a non-neurogenic site and, furthermore, impoverished, due to aging, for the supply of trophic factors such as brain-derived neurotrophic factor. 35 Therefore, Bcl-X L seems to be able to override some of the tissue-imposed limitations for in vivo neuron generation by hNSCs.
In conclusion, in the context of hNSCs research, amounting data indicate that Bcl-X L plays a major role in modulating the generation of neurons from both rodent-and human-derived stem cells, [7] [8] [9] [10] and present work. Here, we contribute data indicating a more general role of Bcl-X L , controlling the balance between the generation of neurons and glia from differentiating immortalized and non-immortalized hNSCs. In future work, it will be important to analyze the mechanisms of action of Bcl-X L at the molecular level, and also the interaction of Bcl-X L overexpressing cells with the surrounding environment after transplantation.
Materials and Methods
Cell culture Cell lines of hNSCs. In this study, we have used control and Bcl-X L overexpressing hNSCs derived from the hNS1 cell line (whose properties have been extensively described elsewhere). 8, 27, 28, 30, 37 This is a v-myc immortalized, nontransformed, human fetal forebrain-derived, multipotent, and clonal cell line of neural stem cells. hNS1 cell culture conditions are based on a chemically defined HSC-medium supplemented with 20 ng/ml of each epidermal growth factor (EGF) and basic fibroblast growth factor (FGF2). 27 Cells were proliferated at 5% CO 2 and normal atmospheric oxygen levels (resulting in 20% O 2 ). Cultures were differentiated on poly-L-lysine (10-50 mg/ml; Sigma) coated plastic or glass coverslips, by withdrawal of growth factors (EGF and FGF2) and addition of 0.5% heat-inactivated fetal bovine serum (FBS), for 12 days or the indicated times, at 5% O 2 and 5% CO 2 in a dual control O 2 -CO 2 incubator (Forma). Non-immortalized forebrain hNSCs. Tissue was obtained from an aborted human fetus of 10 weeks gestational age (Lund University Hospital/ Wallenberg Neuroscience Center; Dr Bengt Juliusson; Lund, Sweden). The tissue was donated for research after informed consent, and following EU directives, NECTAR recommendations, and Spanish law RD 42/1988. All procedures did follow Society for Neuroscience recommendations, and were also approved by the Bioethics of Research Committee of the University Autónoma of Madrid (Spain). Tissue pieces were digested to generate adherent primary cultures (2 Â 10 5 cells per well of a 24-well plate), passed two times, and used for experimentation. Cells (secondary cultures) were grown as adherent cultures in the standard medium for hNSCs (i.e., under the influence of EGF and bFGF, 20 ng/ml each).
BrdU incorporation. To study cell proliferation during differentiation experiments, and Bcl-X L effects on it, cultures were pulsed with BrdU (Sigma) under three different experimental designs.
Experiment 1: general cell proliferation rate. BrdU (10 mM) was applied for 2 h at days 0, 1, 3, 5, 7, 9, or 12 of the differentiation time course, and the cells were immediately fixed after the BrdU pulse for ICC.
Experiment 2: labeling of proliferating precursors that, after completion of the 12-day differentiation period, yielded b-III-tubulin þ or GFAP þ cells (birth dating). BrdU (1 mM) pulse was applied during 24 h at differentiation days 1, 3, 6, or 8 and the cells were let to differentiate until day 12 being subsequently fixed.
Experiment 3: proliferation of Nestin, b-III-tubulin, GFAP or vimentin precursors: BrdU (1 mM) was applied as in Experiment 2 but the cells were fixed immediately afterwards.
Bcl-X L overexpression in hNSCs. The generation of stable Bcl-X L overexpressing hNSCs (hNS1 subclone 5) was previously described. 8 Since continued Bcl-X L expression in selected clones could result in changes in the cell's biology not directly linked to Bcl-X L actions, we have also studied Bcl-X L effects at a shorter time scale (days after transfection) (compare experiments shown in Figures  2 and 3) . To this end, we infected control hNS1 cells with murine leukemia virusderived, vesicular stomatitis virus glycoprotein pseudotyped retroviral vector stocks (generated in HEK 293 cells using the pVP-pack Stratagene system). Vectors had the following structure. Control vector: LTR-(empty)-IRES-RhGFP-LTR. Bcl-X L vector: LTR-(Bcl-X L )-IRES-RhGFP-LTR. (Rh-GFP stands for humanized Renilla raniformis-GFP.) Rh-GFP was subcloned into the retroviral backbone from the pFB-RhGFP plasmid. Titers were determined on HEK293 cells, and retroviral particles were used to infect hNS1 cells at a multiplicity of infection of one particle per cell. Cells were plated (day 0) in proliferation medium and differentiation was started at day 1. On day 2, cells were infected with retroviral stocks (prepared in Dulbecco's modified Eagle's medium/F-12 containing 5% FBS) for 4 h. After that, the regular differentiation medium was replaced, and the cells were let to differentiate until day 12.
For infection of non-immortalized forebrain hNSCs, cells were seeded at 2 Â 10 5 cells/cm 2 (day 0) and infected in the same way as for hNS1, at day 1. On day 2, differentiation was started, by adding regular differentiation medium.
ICC and immunoblotting (WB). At the specified time points, the cultures were rinsed with PBS and fixed for 10 min in freshly prepared 4% PFA/PHEM/4% sucrose. 38 Cultures were blocked for 1 h in 10% normal horse serum, 0.25% Triton X-100 in PBS and incubated overnight at 41C with mouse monoclonal antibodies against b-III-tubulin (1 : 1000; Sigma), GFAP (1 : 1000; Sigma), Nestin (1 : 500; Transduction Laboratories), vimentin (1 : 1000, Santa Cruz) and Map-2 (1 : 1000; Sigma) or monoclonal rat antibodies against BrdU (1 : 500; Abcam, UK) or rabbit antiserum against Ki-67 (1 : 3000; Lab Vision, UK), cleaved caspase-3 (1 : 100; Cell Signaling) synapsin-I (1 : 500; Chemicon) and GFAP (1 : 2000; DakoCytomation, Denmark).
On the next day, the cultures were incubated with biotinylated horse anti-mouse antibodies (1 : 200; Vector Laboratories) followed by streptavidin-CY3 (1 : 300, Jackson Immunoresearch) or FITC-conjugated antibodies (goat anti-rat, or -goat anti-rabbit, 1 : 200; Jackson Immunoresearch) or CY3-conjugated (goat anti-mouse; 1 : 300, Jackson Immunoresearch) or CY5-conjugated antibodies (donkey antirabbit; 1 : 300, Jackson Immunoresearch. For non-fluorescent ICC, samples were developed using the Vector ABC kit followed by diaminobenzidine (DAB) development. Cell nuclei were counterstained with Hoechst 33258 (Molecular Probes, Eugene, OR, USA) at 0.2 mg/ml in PBS. For BrdU ICC, before incubation with the first antibody, fixed cultures were treated with 2 M HCl at 371C for 30 min, followed by three rinses in 0.1 M borate buffer (pH 8.9). For double ICC for BrdU and other antigens, BrdU processing and staining was performed as a second ICC round. Cell nuclei staining in BrdU ICCs was performed using propidium iodide (PI; Sigma) (1 mg/ml in PBS) at the end of the staining process. For western analysis, 30 mg of protein from dividing or differentiated cultures were assayed. Samples were electrophoresed and transferred to nitrocellulose membranes overnight. Primary antibodies were mAb anti-b-actin (1 : 5000; Sigma) and rabbit polyclonal anti-Bcl-X L (1 : 1000; Transduction Laboratories). The blots were developed using peroxidaseconjugated horse anti-mouse (horse anti-mouse peroxidase (HAMPO), 1 : 5000; Vector Laboratories) or goat anti-rabbit antibodies (goat anti-rabbit peroxidase (GARPO), 1 : 10 000; Nordic Immune) and developed using the ECL system (Amersham Biosciences, Arlington Heights, IL, USA).
Cell death. To study cell death parameters during differentiation of hNS1 and Bcl-X L overexpressing cells, we performed the following experiments combining different techniques:
(a) The number of alive and dying-dead cells was quantified in alive cultures stained with calcein-AM/PI (1 mM calcein-AM (Molecular Probes) and 4 mM PI (Sigma)). Cells were stained for 15 min at 371C and photographed, for offline quantification. Green cells are alive cells, while red-stained nuclei identify dead or dying cells.
(b) Analysis of Annexin V þ cells, and nuclear morphology: phosphatidylserine exposure on the outer leaflet of the plasma membrane 39 was detected using the fluorescent dye Annexin V-CY5 (Annexin-V-CY5 detection Kit (Abcam) according to the manufacturer's instructions. In brief, at specified time points culture medium was replaced by Annexin V binding buffer, then 1 ml of Annexin V-CY5 antibody was added and the cells were incubated in this solution for 5 min at room temperature. Nuclei were counterstained with Hoechst 33258 (Molecular Probes, 0.2 mg/ml in PBS, for 10 min). Dying-dead cells were identified by showing a condensed or fragmented nucleus.
(c) Determination of the sub-G 0 /G 1 cell population by flow cytometry: 40 cells were trypsinized, washed in PBS, fixed with 70% ethanol at À201C, and stored at À201C until all the time points were collected. At the time of analysis, cells were incubated in the staining solution for 30 min at 371C (PBS containing 0.1% of sodium citrate, 0.3% of NP-40, 0.02 mg/ml of RNase, and 0.05 mg/ml of PI (Sigma)). DNA content was determined using a fluorescence-activated cell sorter, FACS Calibur flow cytometer (BD Bioscience). A total of 10 000 events were acquired per sample and data were analyzed by CellQuest Software (BD Bioscience).
Image and data analyses on cell cultures. Analyses and photography of fluorescent-or DAB-immunostained cultures were carried out in an inverted Zeiss (Oberkochen, Germany) Axiovert 135 or Leica (Nussloch, Germany) DM IRB (equipped with a digital camera Leica DC100) microscopes. In some experiments, digitized images were captured using Leica IM500 Software. Image analyses were performed using NIH Image Software. Statistical tests were run using Prophet Software (NIH). Results are shown as the average7S.E.M. of data from four to five experiments, unless stated otherwise.
In vivo transplantation. Aged female Wistar rats (23 months old), housed and treated according to the European Community guidelines (86/609/EEC) were anesthetized with a mix of Ketamine and Dontor, and grafted onto the right striatum with cellular suspensions of proliferating control hNS1 cells (n ¼ 5) or Bcl-X L -hNS1 cells (n ¼ 5), at the following coordinates (in mm, tooth bar set at À2.3): anteroposterior (AP) ¼ þ 1; medio-lateral (ML) ¼ À3; dorso-ventral (DV) (from dura) ¼ À4.5. A total of 400 000 cells were implanted as a single deposit (cell density of 150-200 000 cells/ml). The animals were immune suppressed with cyclosporine A (Neoral; Novartis) at 100 mg/ml in drinking water, starting 48 h before grafting. Four weeks after grafting, rats were intracardially perfused with freshly prepared, buffered 4% paraformaldehyde. Brains were post-fixed for 12 h, dehydrated in 30% sucrose, and sectioned (30 mm, freezing microtome) for free-floating immunohistochemistry analyses. Serial sections were processed for monoclonal anti-hNuc (MAB 1281; 1 : 500; Chemicon) to detect all grafted and surviving human cells. Migrating neuroblasts and immature neurons were detected using anti-Dcx antibodies (C-18; 1 : 1000; Santa Cruz Biotechnology), and human neurons were specifically stained using an anti-human neuron-specific enolase antibody (MAB324; 1 : 2000; Chemicon). Undifferentiated cells were detected using polyclonal anti-Nestin antibody (1 : 1000; Abcam). Astroglial cells were stained with a polyclonal antibody anti-GFAP (1 : 2000; Dako, Denmark). For the unambiguous detection of GFAP, Nestin, or Dcx in human cells, double IHC was performed combining these antibodies with those for hNuc. Secondary antibodies were biotinylated horse anti-mouse (1 : 200; BA2001; Vector Laboratories), followed by ABC (Vector Laboratories) and Ni-DAB reaction. For immunofluorescence (IF) secondary antibodies were conjugated to Texas Red (horse anti-mouse; 1 : 100; Vector Laboratories), Alexa 488 (goat anti-rabbit; 1 : 400; Molecular Probes), or FITC (donkey anti-goat; 1 : 200; Jackson Immunoresearch).
Single IF or DAB sections were analyzed on a Leica DM IRB inverted fluorescence microscope. For double IF analyses, sections were analyzed on a Microradiance Confocal microscope (Bio-Rad, Hercules, CA, USA). To determine the phenotype of transplanted cells, hNuc þ cells double immunostained for Nestin, Dcx, or GFAP, were analyzed in confocal z axis serial images (at 63 Â magnification). A total of 3-4 sections per animal (n ¼ 3 in control group and n ¼ 4 in Bcl-X L group) and between 300 and 500 cells per section were analyzed. For each hNuc þ cell, the complete cell nucleus was scanned through the z axis, and only cells with a well circumscribed, immunopositive cell body or nucleus were considered positive for a particular phenotype. Orthogonal projections and volume quantifications were done from low magnifications (25 Â , 40 Â ) z images (0.5-1 mm thickness) using Metamorph software (Universal Imaging Corporation, West Chester, PA, USA).
